{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:08:28Z","timestamp":1791230908849,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.jconrel.2011.03.014","type":"journal-article","created":{"date-parts":[[2011,4,14]],"date-time":"2011-04-14T18:20:33Z","timestamp":1302805233000},"page":"402-410","source":"Crossref","is-referenced-by-count":103,"title":["Chloride channel-mediated brain glioma targeting of chlorotoxin-modified doxorubicine-loaded liposomes"],"prefix":"10.1016","volume":"152","author":[{"given":"Yu","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.jconrel.2011.03.014_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.drudis.2006.10.013","article-title":"Blood\u2013brain barrier delivery","volume":"12","author":"Pardridge","year":"2007","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2011.03.014_bb0010","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.pharmtox.47.120505.105237","article-title":"Drug targeting to the brain","volume":"47","author":"de Boer","year":"2007","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.jconrel.2011.03.014_bb0015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s11095-010-0141-7","article-title":"Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis","volume":"27","author":"Yang","year":"2010","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2011.03.014_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2007.05.022","article-title":"Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123","volume":"122","author":"Tosi","year":"2007","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0025","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2174\/156720107782151269","article-title":"Liposomal drug delivery systems: an update review","volume":"4","author":"Samad","year":"2007","journal-title":"Curr. Drug Deliv."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrd725","article-title":"Drug and gene targeting to the brain with molecular Trojan horses","volume":"1","author":"Pardridge","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/mi.3.2.90","article-title":"Blood\u2013brain barrier drug targeting: the future of brain drug development","volume":"3","author":"Pardridge","year":"2003","journal-title":"Mol. Interv."},{"issue":"33","key":"10.1016\/j.jconrel.2011.03.014_bb0040","doi-asserted-by":"crossref","first-page":"4947","DOI":"10.1016\/j.biomaterials.2007.06.011","article-title":"Active targeting of brain tumors using nanocarriers","volume":"28","author":"B\u00e9duneau","year":"2007","journal-title":"Biomaterials"},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007","journal-title":"Acta Neuropathol."},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1093\/neuonc\/4.4.278","article-title":"Epidemiology of primary brain tumors: current concepts and review of the literature","volume":"4","author":"Wrensch","year":"2002","journal-title":"Neuro Oncol."},{"issue":"8","key":"10.1016\/j.jconrel.2011.03.014_bb0055","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1200\/JCO.2003.05.063","article-title":"Cost of migration: invasion of malignant gliomas and implications for treatment","volume":"21","author":"Giese","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.jconrel.2011.03.014_bb0060","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrc1121","article-title":"Molecular mechanisms of glioma invasiveness: the role of proteases","volume":"3","author":"Rao","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.jconrel.2011.03.014_bb0065","doi-asserted-by":"crossref","first-page":"C1511","DOI":"10.1152\/ajpcell.1996.270.5.C1511","article-title":"Biophysical and pharmacological characterization of chloride currents in human astrocytoma cells","volume":"270","author":"Ullrich","year":"1996","journal-title":"Am. J. Physiol."},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00456-9","article-title":"Expression of voltage activated chloride currents in acute slices of human gliomas","volume":"83","author":"Ullrich","year":"1998","journal-title":"Neuroscience"},{"issue":"11","key":"10.1016\/j.jconrel.2011.03.014_bb0075","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/0041-0101(91)90128-E","article-title":"Chloride channel inhibition by the venom of the scorpion Leiurus quinquestriatus","volume":"29","author":"DeBin","year":"1991","journal-title":"Toxicon"},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0080","doi-asserted-by":"crossref","first-page":"C361","DOI":"10.1152\/ajpcell.1993.264.2.C361","article-title":"Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion","volume":"264","author":"DeBin","year":"1993","journal-title":"Am. J. Physiol."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"issue":"7","key":"10.1016\/j.jconrel.2011.03.014_bb0090","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1023\/A:1006760632766","article-title":"Expression of matrix metalloproteinases and their inhibitors in human brain tumors","volume":"17","author":"Kachra","year":"1999","journal-title":"Clin. Exp. Metastasis"},{"issue":"1","key":"10.1016\/j.jconrel.2011.03.014_bb0095","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1740925X06000044","article-title":"A role for ion channels in glioma cell invasion","volume":"2","author":"Mcferrin","year":"2006","journal-title":"Neuron Glia Biol."},{"issue":"6","key":"10.1016\/j.jconrel.2011.03.014_bb0100","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1074\/jbc.M205662200","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11060-004-0890-4","article-title":"Radiation dosimetry of 131I-chlorotoxin for targeted radiotherapy in glioma-bearing mice","volume":"71","author":"Shen","year":"2005","journal-title":"J. Neurooncol."},{"issue":"14","key":"10.1016\/j.jconrel.2011.03.014_bb0110","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1523\/JNEUROSCI.19-14-05942.1999","article-title":"Modulation of glioma cell migration and invasion using Cl\u2212 and K+ ion channel blockers","volume":"19","author":"Soroceanu","year":"1999","journal-title":"J. Neurosci."},{"issue":"21","key":"10.1016\/j.jconrel.2011.03.014_bb0115","first-page":"4871","article-title":"Use of chlorotoxin for targeting of primary brain tumors","volume":"58","author":"Soroceanu","year":"1998","journal-title":"Cancer Res."},{"issue":"14","key":"10.1016\/j.jconrel.2011.03.014_bb0120","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1158\/0008-5472.CAN-06-3948","article-title":"Tumor paint: a chlorotoxin:Cy5.5 bioconjugate for intraoperative visualization of cancer foci","volume":"67","author":"Veiseh","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0125","first-page":"580","article-title":"Imaging glioma extent with 131I-TM-601","volume":"46","author":"Hockaday","year":"2005","journal-title":"J. Nucl. Med."},{"issue":"22","key":"10.1016\/j.jconrel.2011.03.014_bb0130","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1200\/JCO.2005.05.4569","article-title":"Phase I single-dose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma","volume":"24","author":"Mamelak","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.jconrel.2011.03.014_bb0135","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1021\/nl0502569","article-title":"Optical and MRI multifunctional nanoprobe for targeting gliomas","volume":"5","author":"Veiseh","year":"2005","journal-title":"Nano Lett."},{"issue":"15","key":"10.1016\/j.jconrel.2011.03.014_bb0140","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1158\/0008-5472.CAN-09-1157","article-title":"Specific targeting of brain tumors with an optical\/magnetic resonance imaging nanoprobe across the blood\u2013brain barrier","volume":"69","author":"Veiseh","year":"2009","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0145","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradient in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.jconrel.2011.03.014_bb0150","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<3989::AID-IMMU3989>3.0.CO;2-X","article-title":"Differential reactivity of brain microvascular endothelial cells to TNF reflects the genetic susceptibility to cerebral malaria","volume":"28","author":"Lou","year":"1998","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.jconrel.2011.03.014_bb0155","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1021\/bm060967g","article-title":"Conjugation of arginine\u2013glycine\u2013aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells","volume":"8","author":"Xiong","year":"2007","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2011.03.014_bb0160","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0165","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3171\/jns.2000.92.2.0326","article-title":"An implantable guide-screw system for brain tumor studies in small animals","volume":"92","author":"Lal","year":"2000","journal-title":"J. Neurosurg."},{"issue":"6","key":"10.1016\/j.jconrel.2011.03.014_bb0170","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0092-8674(00)80461-4","article-title":"Molecular mechanisms of endocytosis","volume":"91","author":"Riezman","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.jconrel.2011.03.014_bb0175","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2174\/187152006778699121","article-title":"Pharmacokinetics and pharmacodynamics of lipidic nano-particles in cancer","volume":"6","author":"Allen","year":"2006","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.jconrel.2011.03.014_bb0180","article-title":"Modelling drug release from inert matrix systems: from moving-boundary to continuous-field descriptions","author":"Frenning","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jconrel.2005.03.030","article-title":"Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic","volume":"107","author":"Xiong","year":"2005","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2011.03.014_bb0190","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1021\/mp800218q","article-title":"Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood\u2013brain barrier and survival of brain tumor-bearing animals","volume":"6","author":"Du","year":"2009","journal-title":"Mol. Pharm."},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/10611860500107401","article-title":"Transferrin coupled liposomes as drug delivery carriers for brain targeting of 5-florouracil","volume":"13","author":"Soni","year":"2005","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.jconrel.2011.03.014_bb0200","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00262-006-0273-0","article-title":"Monoclonal antibody 2C5-modified doxorubicin-loaded liposomes with significantly enhanced therapeutic activity against intracranial human brain U-87 MG tumor xenografts in nude mice","volume":"56","author":"Gupta","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.jconrel.2011.03.014_bb0205","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejpb.2010.11.015","article-title":"Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC\/D3 cell line","volume":"77","author":"Markoutsa","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"10","key":"10.1016\/j.jconrel.2011.03.014_bb0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1097\/CAD.0b013e3282a213ce","article-title":"Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects","volume":"18","author":"Garde","year":"2007","journal-title":"Anticancer Drugs"},{"issue":"6","key":"10.1016\/j.jconrel.2011.03.014_bb0215","first-page":"2592","article-title":"Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells","volume":"61","author":"Eliaz","year":"2001","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2011.03.014_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(99)00037-X","article-title":"Mechanisms and kinetics of liposome-cell interactions","volume":"40","author":"D\u00fczg\u00fcnes","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jconrel.2011.03.014_bb0225","first-page":"45","article-title":"The blood\u2013brain and blood-tumor barriers: a review of strategies for increasing drug delivery","volume":"2","author":"Groothuis","year":"2000","journal-title":"Neurooncol."},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0230","first-page":"891","article-title":"Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes","volume":"52","author":"Gabizon","year":"1992","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.jconrel.2011.03.014_bb0235","first-page":"3","article-title":"Passive and active drug targeting: drug delivery to tumors as an example","volume":"197","author":"Torchilin","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"issue":"33","key":"10.1016\/j.jconrel.2011.03.014_bb0240","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1016\/j.biomaterials.2010.07.080","article-title":"Paclitaxel and suramin-loaded core\/shell microspheres in the treatment of brain tumors","volume":"31","author":"Nie","year":"2010","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.jconrel.2011.03.014_bb0245","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/CAD.0b013e328313e172","article-title":"Interest of liposomal doxorubicin as a radiosensitizer in malignant glioma xenografts","volume":"19","author":"Labussi\u00e8re","year":"2008","journal-title":"Anticancer Drugs"},{"issue":"4","key":"10.1016\/j.jconrel.2011.03.014_bb0250","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s11095-010-0353-x","article-title":"In vivo anti-tumor effect of expressing p14ARF-TAT using a FGF2-targeted cationic lipid vector","volume":"28","author":"Niu","year":"2011","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.jconrel.2011.03.014_bb0255","first-page":"39","article-title":"Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide","volume":"30","author":"Jacoby","year":"2010","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.jconrel.2011.03.014_bb0260","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1074\/jbc.M109.066092","article-title":"Annexin A2 is a molecular target for TM601, a peptide with tumor-targeting and anti-angiogenic effects","volume":"285","author":"Kesavan","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911001507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365911001507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T22:04:00Z","timestamp":1560117840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365911001507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S0168365911001507"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2011.03.014","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}